Gastric Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 783-790
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.783
Table 1 Relationship between expression of VEGF-C and CCR7 and clinicopathologic parameters in patients with gastric carcinoma
No. of patientsExpression of VEGF-C
P valueExpression of CCR7
P value
PositiveNegativePositiveNegative
AgeNS*NS
<61 years4621252323
≥61years7241314032
GenderNSNS
Male7138333932
Female4724232423
Tumor sizeNS<0.01
<5 cm5323302132
≥5 cm6539264223
Tumor locationNSNS
Lower third (L)8140414437
Middle third (M)211291110
Upper third (U)1610688
Lauren classificationNSNS
Intestinal5324292528
Diffuse5330233221
Mixed128466
Depth of invasionNS<0.001
T1/224915519
T3/49453415836
Lymph node metastasis<0.001<0.001
Positive6145165011
Negative5717401344
Lymphatic invasion<0.001<0.001
Positive6848205117
Negative5014361238
Vascular invasion<0.01NS
Positive3525102015
Negative8337464340
Stage<0.001<0.001
I, II5519361342
III, IV6343205013
Table 2 Correlation between expression of VEGF-C and CCR7 and lymph node metastasis determined by MSCT and pathological examination
No. of patientsExpression of VEGF-C
P valueExpression of CCR7
P value
PositiveNegativePositiveNegative
Lymph node metastasis1NS3<0.05
Positive21129147
Negative18612513
Lymph node metastasis2<0.01<0.01
Positive19136145
Negative20515515
Table 3 Comparison of MSCT and pathological diagnosis of N stage
Pathologic N stageNo. of patientsN stage determined by MSCT
N0N1N2
N02015123
N1102513
N291171
Table 4 Relationship between expression of VEGF-C and CCR7 after the subdivision and lymph node metastasis
Lymph node metastasisNo. of patientsExpression of VEGF-C and CCR7
CCR7(+) andVEGF-C(+)CCR7(+) andVEGF-C(-)CCR7(+) andVEGF-C(+)CCR7(+) andVEGF-C(-)
Positive6141947
Negative57761034